Journal
BRAIN RESEARCH
Volume 1045, Issue 1-2, Pages 229-233Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.brainres.2005.03.016
Keywords
simvastatin; hydroxymethylglutaryl-coenzyme A reductase inhibitor; dopamine D-1 and D-2 receptors; downregulation; upregulation; Parkinson's disease (PD); 6-OHDA lesion
Categories
Ask authors/readers for more resources
Sprague-Dawley rats with unilateral lesion of the medial forebrain bundle by 6-hydroxydopamine showed marked decrease in the expression of dopamine D-1 and D-2 receptors in the prefrontal cortex. Simvastatin (10 mg/kg/day for 4 weeks) restored receptor expression to control levels. Given the association of dopaminergic dysfunction in the prefrontal cortex and cognitive deficits in Parkinson's disease, these findings may have implication in the treatment of cognitive decline in advanced Parkinson's disease. (C) 2005 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available